Overview

Paclitaxel, Carboplatin And Low Dose Radiation As Induction Therapy In Locally Advanced Head And Neck Cancer

Status:
Completed
Trial end date:
2017-01-31
Target enrollment:
Participant gender:
Summary
This study is being performed utilizing two cycles of Paclitaxel and Carboplatin, plus low doses radiation as initial therapy prior to other treatment (surgery or radiation). The study is assessing if utilization of low doses radiation as a chemoenhancer will further increase the response rate seen with initial therapy.
Phase:
Phase 2
Details
Lead Sponsor:
Susanne Arnold
Collaborator:
Bristol-Myers Squibb
Treatments:
Albumin-Bound Paclitaxel
Carboplatin
Paclitaxel